Abstract
The process of drug discovery and development requires enormous resources and time, with increasing cost for new drug development. Molecular imaging techniques have tremendous potential for improving the efficiency of drug screening, assessing the pharmacokinetics of new drugs, and evaluating drug effects. Appropriate application of molecular imaging to drug discovery and development can markedly reduce costs and the time required for new drug development. This review focuses on the contributions of molecular imaging for drug discovery and development, particularly drug screening, pharmacokinetic, preclinical and clinical drug evaluation, and for personalized and lesionalized medicine.
Keywords: Drug discovery and development process, molecular imaging, drug screening, pharmacokinetic study, preclinical and clinical study, personalized medicine, lesionalized medicine, efficiency of drug screening, drug effects, pharmacokinetic, preclinical and clinical drug evaluation, combinational chemistry technologies, optical imaging, imaging, magnetic resonance imaging (MRI), ultrasound imaging and computed tomography (CT)
Current Pharmaceutical Biotechnology
Title: Applications of Molecular Imaging in Drug Discovery and Development Process
Volume: 12 Issue: 4
Author(s): Byeong-Cheol Ahn
Affiliation:
Keywords: Drug discovery and development process, molecular imaging, drug screening, pharmacokinetic study, preclinical and clinical study, personalized medicine, lesionalized medicine, efficiency of drug screening, drug effects, pharmacokinetic, preclinical and clinical drug evaluation, combinational chemistry technologies, optical imaging, imaging, magnetic resonance imaging (MRI), ultrasound imaging and computed tomography (CT)
Abstract: The process of drug discovery and development requires enormous resources and time, with increasing cost for new drug development. Molecular imaging techniques have tremendous potential for improving the efficiency of drug screening, assessing the pharmacokinetics of new drugs, and evaluating drug effects. Appropriate application of molecular imaging to drug discovery and development can markedly reduce costs and the time required for new drug development. This review focuses on the contributions of molecular imaging for drug discovery and development, particularly drug screening, pharmacokinetic, preclinical and clinical drug evaluation, and for personalized and lesionalized medicine.
Export Options
About this article
Cite this article as:
Ahn Byeong-Cheol, Applications of Molecular Imaging in Drug Discovery and Development Process, Current Pharmaceutical Biotechnology 2011; 12 (4) . https://dx.doi.org/10.2174/138920111795163904
DOI https://dx.doi.org/10.2174/138920111795163904 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets Smart Drug Delivery Systems in Cancer Therapy
Current Drug Targets Cell Cycle Re-Entry in Alzheimers Disease: A Major Neuropathological Characteristic?
Current Alzheimer Research Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Biologic Therapy in Rheumatoid Arthritis
Current Topics in Medicinal Chemistry ATF4, an ER Stress and Hypoxia-Inducible Transcription Factor and its Potential Role in Hypoxia Tolerance and Tumorigenesis
Current Molecular Medicine Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials Regulatory T Cells and Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) Supramolecular Chiro-Biomedical Assays and Enantioselective HPLC Analyses for Evaluation of Profens as Non-Steroidal Anti-Inflammatory Drugs, Potential Anticancer Agents and Common Xenobiotics
Current Drug Discovery Technologies Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design Patent Selections:
Recent Patents on Biomedical Engineering (Discontinued) Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Redox-Sensitive Smart Nanosystems for Drug and Gene Delivery
Current Organic Chemistry Anti-cancer Immunotoxins, Challenges, and Approaches
Current Pharmaceutical Design Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme
Current Molecular Pharmacology Radionuclide Imaging in Drug Development
Current Pharmaceutical Design Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response
Anti-Cancer Agents in Medicinal Chemistry Candidate Susceptibility Genes in Alzheimers Disease Are at High Risk for Being Forgotten - They Dont Give Peace of Mind...
Current Drug Metabolism